Provided by Tiger Trade Technology Pte. Ltd.

Coherus BioSciences

1.31
+0.03002.34%
Post-market: 1.330.0200+1.53%18:55 EST
Volume:972.85K
Turnover:1.25M
Market Cap:158.51M
PE:0.98
High:1.32
Open:1.27
Low:1.25
Close:1.28
52wk High:2.43
52wk Low:0.7100
Shares:121.00M
Float Shares:111.19M
Volume Ratio:1.03
T/O Rate:0.87%
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.34
EPS(LYR):0.2489
ROE:331.11%
ROA:-10.26%
PB:1.81
PE(LYR):5.26

Loading ...

Coherus Oncology Q3 Sales USD 11.571 Million Vs. IBES Estimate USD 13.4 Million

Reuters
·
Nov 20

H.C. Wainwright Remains a Buy on Coherus Biosciences (CHRS)

TIPRANKS
·
Nov 15

Coherus Oncology files $150M mixed securities shelf

TIPRANKS
·
Nov 14

BRIEF-Coherus Oncology Files For Mixed Shelf Offering Of Up To $150 Million- SEC Filing

Reuters
·
Nov 14

Coherus Oncology Inc : Files for Mixed Shelf Offering of up to $150 Mln- SEC Filing

THOMSON REUTERS
·
Nov 14

Coherus Oncology Reports Promising Phase 1b Results for CHS-114 in Head and Neck Cancer

Reuters
·
Nov 07

Coherus Oncology Q3 sales miss estimates, LOQTORZI revenue up 12%

Reuters
·
Nov 07

Coherus BioSciences Q3 Adj. EPS $(0.33) Misses $(0.29) Estimate, Sales $11.571M Miss $13.413M Estimate

Benzinga
·
Nov 07

Coherus Oncology reports Q3 2025 net revenue of $11.2 million and net loss of $38.9 million

Reuters
·
Nov 07

BRIEF-Coherus Oncology Q3 Sales USD 11.571 Million Vs. IBES Estimate USD 13.4 Million

Reuters
·
Nov 07

Press Release: Arvind Sood joins Coherus Oncology as Chief Strategy and Corporate Affairs Officer

Dow Jones
·
Nov 07

Despite shrinking by US$22m in the past week, Coherus Oncology (NASDAQ:CHRS) shareholders are still up 122% over 1 year

Simply Wall St.
·
Oct 28

Coherus Oncology to Participate in Upcoming Investor Conferences

GlobeNewswire
·
Oct 23

4 Biotechnology Stocks Lead Momentum Gains Amid Strong Technicals

Benzinga_recent_news
·
Oct 10

Coherus Oncology Announces Poster Presentation at the 40th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)

GlobeNewswire
·
Oct 03

Coherus Oncology Inc : Maxim Group Raises to Buy From Hold

THOMSON REUTERS
·
Sep 04

Coherus Oncology Raised to Buy From Hold by Maxim Group

Dow Jones
·
Sep 04

Coherus Oncology Inc. to Participate in Baird Global Healthcare Conference in New York

Reuters
·
Sep 03

Coherus Oncology Inc reports results for the quarter ended June 30 - Earnings Summary

Reuters
·
Aug 08

Coherus BioSciences Q2 Adj. EPS $(0.34) Misses $(0.28) Estimate, Sales $10.254M Miss $10.946M Estimate

Benzinga
·
Aug 08